Remedium Lifecare Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 11.83 | 21.85 | 82.23 |
| Operating Expense | 11.57 | 22.58 | 82.75 |
| Net Profit | 0.07 | -0.37 | -2.64 |
| Net Profit Margin | 0.59 | -1.69 | -3.21 |
| Earning Per Share | TBA | TBA | -0.07 |
| EBIDTA | 0.26 | -0.73 | -0.51 |
| Effective Tax Rate | TBA | TBA | -101.92 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 11.83 |
| Operating Expense | 11.57 |
| Net Profit | 0.07 |
| Net Profit Margin | 0.59 |
| Earning Per Share | TBA |
| EBIDTA | 0.26 |
| Effective Tax Rate | TBA |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 222.50 | 4,041.71 | 509.84 |
| Operating Expenses Annual | 224.31 | 4,008.40 | 502.37 |
| Operating Profit Annual | 8.99 | 54.38 | 7.47 |
| Interest Annual | 5.29 | 3.87 | -0.08 |
| Depreciation | 0.04 | 0.06 | 0.15 |
| Net Profit Annual | 1.53 | 32.73 | 5.43 |
| Tax Annual | 2.13 | 17.72 | 1.97 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 222.50 |
| Operating Expenses Annual | 224.31 |
| Operating Profit Annual | 8.99 |
| Interest Annual | 5.29 |
| Depreciation | 0.04 |
| Net Profit Annual | 1.53 |
| Tax Annual | 2.13 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 1.52 | 21.86 | 1.44 |
| Cash Flow from Operations | -1,078.63 | -74.16 | 20.50 |
| Cash Flow from Investing | 0.06 | TBA | -0.04 |
| Cash Flow from Financing | 1,078.40 | 53.83 | -0.04 |
| Cash Flow at the End | 1.36 | 1.52 | 21.86 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 1.52 |
| Cash Flow from Operations | -1,078.63 |
| Cash Flow from Investing | 0.06 |
| Cash Flow from Financing | 1,078.40 |
| Cash Flow at the End | 1.36 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 5.10 | 1.37 | 1.57 |
| PBIT Margin (%) | 5.08 | 1.37 | 1.54 |
| PBT Margin (%) | 4.41 | 1.08 | -1.88 |
| Net PROFIT Margin (%) | 0.69 | 0.81 | 1.07 |
| Return On Networth / Equity (%) | 3.55 | 122.77 | 70.98 |
| Return On Networth /Employed (%) | 1.76 | 99.50 | 102.61 |
| Return On Assets (%) | 0.24 | 58.95 | 70.93 |
| Total Debt / Equity (X) | 13.90 | 1.08 | TBA |
| Asset Turnover Ratio (%) | 0.35 | 72.80 | 66.60 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 5.10 |
| PBIT Margin (%) | 5.08 |
| PBT Margin (%) | 4.41 |
| Net PROFIT Margin (%) | 0.69 |
| Return On Networth / Equity (%) | 3.55 |
| Return On Networth /Employed (%) | 1.76 |
| Return On Assets (%) | 0.24 |
| Total Debt / Equity (X) | 13.90 |
| Asset Turnover Ratio (%) | 0.35 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 0.01 | 0.05 | 0.08 |
| Total Current Assets Annual | 1,539.54 | 1,947.85 | 1,154.14 |
| Non Current Assets Annual | 0.11 | 0.07 | 0.09 |
| Total Shareholders Funds Annual | 43.30 | 42.96 | 10.36 |
| Total Assets Annual | 1,539.65 | 1,947.92 | 1,154.22 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 0.01 |
| Total Current Assets Annual | 1,539.54 |
| Non Current Assets Annual | 0.11 |
| Total Shareholders Funds Annual | 43.30 |
| Total Assets Annual | 1,539.65 |
EPS (INR)
Expected
0.10
Reported
0.10
Surprise
0.00%
Jun 2025
EPS beaten by 0.00%
Mar 2025
EPS beaten by 0.00%
